Medications Flashcards
Promote red blood cell production and improve anemia associated with CKD.
*Increases risk of stroke, heart attack, heart failure, blood clots, and death
*Possible GI distress, increased appetite, increased BP, iron deficiency, low folate and B12
Erythropoietin-stimulating agents (ESAS)
*Darbepoetin alfa (aranesp)
*Epoetin alfa (Epogen, Procrit)
*Methoxy polyethylene-glycol beta (Mircera)
Work by inhibiting a key step in hepatic cholesterol synthesis leading to decreased levels of total cholesterol
*Little to no effect on CVD outcomes despite LDL lowering effect
*Side effects: n/v/d/c; headache, rash, muscle pain, rhabdo, liver failure
*Do not take with grapefruit juice
*Monitor ALT and AST
HMG-CoA Reductase Inibitors (Statins)
*Simvastatin (Zocor)
*Lovastatin (Mevacor)
*Fluvastatin (Livalo)
*Atorvastatin (Lipator)
*Pravastatin (Pravachol)
Lower TG levels by reducing liver production of VLDL and speeding up removal of TG in blood
*Side effects: n/v/d, liver inflammation, decreased potassium and BG, gallstones (long-term)
*Monitor and address above.
Fibrates
*Gemfibrozil (Lopid)
*Clofibrate (Atromid-S)
*Fenofibrate (Tricor)
Act on brush border of the intestine by preventing absorption of cholesterol in the intestine
*Side effects: diarrhea, loss of appetite, upset stomach, fatty stools
Nonstatin cholesterol lowering meds
*Ezetimibe (Zetia)
Reduce production of TG in liver and enhance clearance of TG from circulating VLDL.
*Side effects: indigestion, altered taste, burping, constipation, throat pain, dental pain; muscle and joint pain, swelling, afib, increased bleeding
*Not rec for with fish or shellfish allergies
Omega-3 Fatty Acid (Eicosapentaenoic Acid/EPA)
*Lovaza
Bind with cholesterol containing bile acids in intestines and eliminated in the stool
*Side effects: prevent abs. of fat-soluble vitamins, decreased calcium abs., n/v/c, heartburn
*May increase ALT, AST, alk phos, phos, and TG
*May reduce potassium
Bile Acid Sequestrants
*Cholestyramine (Questran, Prevalite)
*Colestipol (Cholestid)
*Colesevelam (Welchol)
Lowers total cholesterol and triglycerides at high doses
*Can increase HDL
*May raise BG and uric acid levels, cause flushing, and/or exacerbate hypotension
Niacin (nicotinic acid/Vitamin B3)
*Does not include niacinamide form
Stimulate beta cell production of insulin in T2DM
*Onset of action within 1.5 hours
*Metabolized in liver and cleared in urine, risk of drug build-up and lower BG.
*Rise of hypoglycemia
*Dose adjustments needed with CKD, not rec. for GFR < 50
Sulfonylureas
*Glimepiride (Amaryl)
*Glipizide (Glucatrol)
*Glyburide (Glynase, Micronase)
Stimulate beta cells of pancreas.
*Quick onset with short action time (take w/ meals)
*Effective on postprandial BG and those with irregular meal patterns.
*Possible weight gain, may need dose adj. with CKD
*Take 15 minutes before meal.
Meglitinides
*Nateglinide (Starlix)
*Repaglinide (Prandin)
Decrease hepatic glucose production and provide some increased peripheral sensitivity
*Do not cause hypoglycemia
*SE: bloating, diarrhea, flatulence
*Dose adj. needed with CKD; do not use with GFR < 30
*Monitor for lactic acidosis
Biguanides
*Metformin (Glucophage, Riomet)
Increase insulin sensitivity and are active only in presence of insulin
*May worsen heart failure by increasing fluid retention, may increase risk of bone fractures
*No dose adjustments with CKD
*Possible weight gain
Thiazolidinediones (TZDs)
*Pioglitazone (Actos)
Delay digestion and absorption of CHO in GI track
*No studies with Cr > 2 and GFR < 25
a-Glucosidase Inhibitors
*Acarabose (Precose)
Block action of __, an enzyme that destroys incretin
*Incretin helps body produce more insulin only when needed and reduce amount of glucose being produced by liver when not needed
*SE: n/d, stomach pain, headache, sore throat
*Dose adj. may be needed with CKD
Dipeptidyl Peptidase-4 Inhibitors (DPP-4 Inhibitors)
*Sitagliptin (Januvia)
*Saxagliptin (Onglyza)
*Linagliptin (Tradjenta)
Prevent kidneys from reabsorbing glucose back into blood which allows excretion into urine
*Risk of kidney failure, dose adj. needed with CKD and avoid with GFR < 30
*May show signs of hyperkalemia, hypotension, or ketoacidosis
*Increased risk of UTI and dehydration
*Hypoglycemia may occur when used with insulin or meds that increase insulin production
Sodium-glucose cotransporter (SGLT-2) Inhibitors
*Canagiflozin (Invokana)
*Dapaglifozin (Farxiga)
*Empagliflozin (Jardiance)
*Erugliflozin (Steglatro)
*Class possibly becoming new standard of care s/p promising results in phase 3 HF trials
Mimick functions of natural incretin hormones that help lower post-meal BG levels
*Stimulate release of insulin by pancrease
*SE: n/v/d/c, indigestion, loss of appetite, headache, dizziness, sweating
Glucagon-like Peptide-1 Receptor Agonists
*Exenatide (Bydureon, Byetta)
*Liraglutide (Victoza, Saxenda)
*Dulaglutide (Trulicity)
*Semaglutide (Ozempic)
Hormone usually made by pancreas that allows glucose from CHO to be used by body.
Insulin
Begins working within 15 minutes
Peaks in 1-2 hours
Duration of 3-4 hours
Rapid-acting insulin (can be used in pumps)
*Lispro (Humalog)
*Aspart (Novolog)
Begins to lower BG levels within 30 minutes
Max effect 2-5 hours (regular), 1-2 hours (human)
Duration of 8 hours (regular), 2-3 hours (human)
Short-acting insulin (not used in pumps)
*Regular (Novolin-R)
*Insulin human (Humulin-R)
Begins working in about 1-2 hours
Peaks at 4-12 hours
Duration of 18-24 hours
Used with other types
Intermediate-acting insulin
*NPH (Novolin-N)
*Humulin-N
No peak, steady level
Begins in 1-2 hour, continuous release effective for 24 hours
Long-acting insulin
*Glargine (Toujeo, Lantus)
*Detemir (Levemir)
*Degludec (Tresiba)
Useful for patients unable to mix insulin doses themselves
Often used with T2DM
Specific amounts of intermediate- and short-acting in one bottle or pen
Generally taken 2-3 times/day before meals
Insulin mixtures
Inhibit gastric smooth muscle relaxation
Accelerates intestinal transit and gastric emptying
Relaxes upper small intestine –> decreases reflux into esophagus and improving acid clearance
*Primarily used for gastroparesis and esophageal reflux
*SE: n/v/d, confusion, uncontrolled muscle movements
*May alter insulin requirements –> monitor BG
Dopaminergic-blocking agent
*Metoclopramide (Reglan)
Used for pathological gastric hypersecretion (ex. GERD) when lifestyle changes do not work
*SE: n/v/d/c, dry mouth, anorexia, abd pain, flatulence, dizziness, headache, irregular heartbeat, alopecia
Histamine H2-Receptor Antagonists
*Cimetidine (Tagamet)
*Famotidine (Pepcid)–contains calcium and magnesium
*Ranitidine (Zantac)–linked to carcinogen in generics
Prevent acid-related conditions (ex: GERD, ulcers)
Used in combo with abx to treat H.Pylori infections
Associated with increased risk of heart attack and risk of CKD
*SE: n/c/d, headache
*Reduced iron, mag, and B12 absorption
*Metabolized by liver
Proton-Pump Inhibitors
*Esomeprazole (Nexium)
*Lansomeprazole (Prevacid)
*Omeprazole (Prilosec)
*Pantoprazole (Protonix)